The use of AI in biotechnology is changing faster than the rules governing either technology
The rapid integration of AI into biotechnology, such as the creation of AI-designed viruses, is outpacing current regulatory frameworks. Experts warn that while these tools offer significant medical benefits, they also pose risks that existing laws are not equipped to manage.
Why it matters
The intersection of AI and synthetic biology presents a dual-use dilemma that requires urgent policy updates to prevent misuse and unintended biological consequences.
Just_Super/Getty Images The use of AI in biotechnology is changing faster than the rules governing either technology Published: August 17, 2026 8:11pm EDT https://theconversation.com/the-use-of-ai-in-biotechnology-is-changing-faster-than-the-rules-governing-either-technology-289796 https://theconversation.com/the-use-of-ai-in-biotechnology-is-changing-faster-than-the-rules-governing-either-technology-289796 Link copied Share article Share article
Copy link Email Bluesky Facebook WhatsApp Messenger LinkedIn X (Twitter) Print article
The recent announcement of novel, viable viruses created by artificial intelligence (AI) was celebrated as a major advance in the fight against antibiotic resistance . But it also raised urgent concerns about regulation.
Alongside precision gene-editing technologies such as CRISPR/Cas9 and synthetic biology , AI is now making it increasingly possible to design and alter entire biological systems.
These technologies could clearly do a lot of good. The new AI-designed viruses – bacteriophages that exclusively kill bacteria – rapidly overcame antibiotic-resistant strains of E. coli.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in